(1) Synthesis of SGLT2 inhibitors Canagliflozin and Ipragliflozin(2) Synthesis of Ganglioside Hp-s1 and DSGA Analogues with S-Glycosylation
碩士 === 國立中興大學 === 化學系所 === 104 === Canagliflozin, Ipragliflozi and Dapagliflozin are SGLT2 inhibitors that have potential use in the treatment of type II diabetes. All of them are C−Glycoside structure. Starting with 2-clorothiophene, Benzothiophene and 2- ethoxybenzene furnishes two thiophene struc...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Others |
Language: | zh-TW |
Published: |
2016
|
Online Access: | http://ndltd.ncl.edu.tw/handle/87363228345742914477 |
id |
ndltd-TW-104NCHU5065068 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-TW-104NCHU50650682017-01-11T04:08:09Z http://ndltd.ncl.edu.tw/handle/87363228345742914477 (1) Synthesis of SGLT2 inhibitors Canagliflozin and Ipragliflozin(2) Synthesis of Ganglioside Hp-s1 and DSGA Analogues with S-Glycosylation (1) 合成SGLT2抑制劑Canagliflozin及Ipragliflozin(2) 利用s-醣苷化反應合成Hp-s1及DSGA衍生物 Chih-Wu Liang 梁致武 碩士 國立中興大學 化學系所 104 Canagliflozin, Ipragliflozi and Dapagliflozin are SGLT2 inhibitors that have potential use in the treatment of type II diabetes. All of them are C−Glycoside structure. Starting with 2-clorothiophene, Benzothiophene and 2- ethoxybenzene furnishes two thiophene structures and one benzene structure. After C-glycosylation reactions afford three C−Glycoside structures, reduction a methoxy, Canagliflozin, Ipragliflozi and Dapagliflozin were obtained. In second part of thesis, synthesis of analogues of ganglioside Hp-s1 and DSG-A is presented. In order to optimize the neuritogenic activity, we change the oxygen atom between central glucosyl moiety and phytosphingosine part with sulfur atom of ganglioside Hp-s1 and DSG-A to syntheisized new analogues 67 and 70. Shun-Yuan Luo 羅順原 2016 學位論文 ; thesis 178 zh-TW |
collection |
NDLTD |
language |
zh-TW |
format |
Others
|
sources |
NDLTD |
description |
碩士 === 國立中興大學 === 化學系所 === 104 === Canagliflozin, Ipragliflozi and Dapagliflozin are SGLT2 inhibitors that have potential use in the treatment of type II diabetes. All of them are C−Glycoside structure. Starting with 2-clorothiophene, Benzothiophene and 2- ethoxybenzene furnishes two thiophene structures and one benzene structure. After C-glycosylation reactions afford three C−Glycoside structures, reduction a methoxy, Canagliflozin, Ipragliflozi and Dapagliflozin were obtained.
In second part of thesis, synthesis of analogues of ganglioside Hp-s1 and DSG-A is presented. In order to optimize the neuritogenic activity, we change the oxygen atom between central glucosyl moiety and phytosphingosine part with sulfur atom of ganglioside Hp-s1 and DSG-A to syntheisized new analogues 67 and 70.
|
author2 |
Shun-Yuan Luo |
author_facet |
Shun-Yuan Luo Chih-Wu Liang 梁致武 |
author |
Chih-Wu Liang 梁致武 |
spellingShingle |
Chih-Wu Liang 梁致武 (1) Synthesis of SGLT2 inhibitors Canagliflozin and Ipragliflozin(2) Synthesis of Ganglioside Hp-s1 and DSGA Analogues with S-Glycosylation |
author_sort |
Chih-Wu Liang |
title |
(1) Synthesis of SGLT2 inhibitors Canagliflozin and Ipragliflozin(2) Synthesis of Ganglioside Hp-s1 and DSGA Analogues with S-Glycosylation |
title_short |
(1) Synthesis of SGLT2 inhibitors Canagliflozin and Ipragliflozin(2) Synthesis of Ganglioside Hp-s1 and DSGA Analogues with S-Glycosylation |
title_full |
(1) Synthesis of SGLT2 inhibitors Canagliflozin and Ipragliflozin(2) Synthesis of Ganglioside Hp-s1 and DSGA Analogues with S-Glycosylation |
title_fullStr |
(1) Synthesis of SGLT2 inhibitors Canagliflozin and Ipragliflozin(2) Synthesis of Ganglioside Hp-s1 and DSGA Analogues with S-Glycosylation |
title_full_unstemmed |
(1) Synthesis of SGLT2 inhibitors Canagliflozin and Ipragliflozin(2) Synthesis of Ganglioside Hp-s1 and DSGA Analogues with S-Glycosylation |
title_sort |
(1) synthesis of sglt2 inhibitors canagliflozin and ipragliflozin(2) synthesis of ganglioside hp-s1 and dsga analogues with s-glycosylation |
publishDate |
2016 |
url |
http://ndltd.ncl.edu.tw/handle/87363228345742914477 |
work_keys_str_mv |
AT chihwuliang 1synthesisofsglt2inhibitorscanagliflozinandipragliflozin2synthesisofgangliosidehps1anddsgaanalogueswithsglycosylation AT liángzhìwǔ 1synthesisofsglt2inhibitorscanagliflozinandipragliflozin2synthesisofgangliosidehps1anddsgaanalogueswithsglycosylation AT chihwuliang 1héchéngsglt2yìzhìjìcanagliflozinjíipragliflozin2lìyòngstánggānhuàfǎnyīnghéchénghps1jídsgayǎnshēngwù AT liángzhìwǔ 1héchéngsglt2yìzhìjìcanagliflozinjíipragliflozin2lìyòngstánggānhuàfǎnyīnghéchénghps1jídsgayǎnshēngwù |
_version_ |
1718407585222098944 |